Tesamorelin/Ipamorelin

Tesamorelin / Ipamorelin: The "Metabolic Synergist"

The blend of Tesamorelin and Ipamorelin is a strategic combination of two distinct Growth Hormone Secretagogues (GHS). By pairing a Growth Hormone Releasing Hormone (GHRH) analogue with a Ghrelin receptor agonist, this blend creates a "dual-signal" approach to maximize the body’s natural growth hormone production.

While Tesamorelin acts as a precision tool for fat loss, Ipamorelin acts as a stabilizer and enhancer, making this one of the most popular combinations for body recomposition.

• Dual-Mechanism Stimulation: Tesamorelin mimics the signal to start a GH pulse, while Ipamorelin inhibits Somatostatin (the "stop" signal). This allows the pituitary gland to release a more significant and sustained pulse of growth hormone than either peptide could achieve alone.

• Selective Visceral Targeting: The Tesamorelin component maintains its "guided missile" effect on deep abdominal fat (VAT), while the addition of Ipamorelin supports a more generalized reduction in subcutaneous fat.

• Muscle Preservation and Recovery: Ipamorelin’s influence on GH levels aids in protein synthesis and nitrogen retention, ensuring that as the body burns fat, lean muscle mass is protected and recovery from physical exertion is accelerated.

• Enhanced Safety Profile: Ipamorelin is known as a "clean" secretagogue; it does not significantly increase cortisol, prolactin, or aldosterone. This keeps the blend focused on metabolic benefits without the "jittery" or hunger-inducing side effects common in older peptides like GHRP-2 or GHRP-6.

Essentially, while Tesamorelin is a specialist for visceral fat, adding Ipamorelin turns the protocol into a comprehensive metabolic optimizer, boosting the total GH output while maintaining high precision.

RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION